Cited 9 time in
Effects of Xanthium stramarium and Psoralea corylifolia Extracts Combined with UVA1 Irradiation on the Cell Proliferation and TGF- beta 1 Expression of Keloid Fibroblasts
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Sun Yi | - |
| dc.contributor.author | Park, Ji-Youn | - |
| dc.contributor.author | Kim, Chul-Ho | - |
| dc.contributor.author | Kang, Sung Un | - |
| dc.contributor.author | Kim, Jong-Hyun | - |
| dc.contributor.author | Bark, Ki-Min | - |
| dc.contributor.author | Kim, Tae Heung | - |
| dc.contributor.author | Shin, Sung Chul | - |
| dc.contributor.author | Kang, Hee Young | - |
| dc.date.accessioned | 2022-12-27T00:31:25Z | - |
| dc.date.available | 2022-12-27T00:31:25Z | - |
| dc.date.issued | 2013-08 | - |
| dc.identifier.issn | 1013-9087 | - |
| dc.identifier.issn | 2005-3894 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/20555 | - |
| dc.description.abstract | Background: Xanthium stramarium (XAS) and Psoralea corylifolia (PSC), phototoxic oriental medicinal plants, has been used in traditional medicines in Asian countries. Objective: The effects of highly purified XAS or PSC extract combined with ultraviolet A1 (UVA1) irradiation on cell proliferation and transforming growth factor-beta1 (TGF-beta 1) expression of the keloid fibroblast were being investigated to define potential therapeutic uses for keloid treatments. Methods: The keloid fibroblasts were treated with XAS or PSC alone or in the combination with UVA1 irradiation. The cell viability, apoptosis, and expression of TGF-beta 1 and collagen I were investigated. Results: XAS and PSC in combination with UVA1 irradiation suppressed cell proliferation and induced apoptosis of keloid fibroblasts. Furthermore, the XAS and PSC in combination with UVA1 irradiation inhibited TGF-beta 1 expression and collagen synthesis in keloid fibroblasts. Conclusion: These findings may open up the possibility of clinically used XAS or PSC in combination with UVA1 irradiation for keloid treatments. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KOREAN DERMATOLOGICAL ASSOC | - |
| dc.title | Effects of Xanthium stramarium and Psoralea corylifolia Extracts Combined with UVA1 Irradiation on the Cell Proliferation and TGF- beta 1 Expression of Keloid Fibroblasts | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.5021/ad.2013.25.3.304 | - |
| dc.identifier.scopusid | 2-s2.0-84882610689 | - |
| dc.identifier.wosid | 000323687000006 | - |
| dc.identifier.bibliographicCitation | ANNALS OF DERMATOLOGY, v.25, no.3, pp 304 - 309 | - |
| dc.citation.title | ANNALS OF DERMATOLOGY | - |
| dc.citation.volume | 25 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 304 | - |
| dc.citation.endPage | 309 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART001793379 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Dermatology | - |
| dc.relation.journalWebOfScienceCategory | Dermatology | - |
| dc.subject.keywordPlus | SCLERODERMA | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordAuthor | Apoptosis | - |
| dc.subject.keywordAuthor | Keloid | - |
| dc.subject.keywordAuthor | Psoralea corylifolia | - |
| dc.subject.keywordAuthor | Transforming growth factor-beta 1 | - |
| dc.subject.keywordAuthor | Xanthium stramarium | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
